Physician profile
Jonathan D Lee
NPI 1174904361
$2,022.77
in general payments reported to CMS, 2019-2025
17 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,430 · 2020: $14.54 · 2021: $63.84 · 2022: $34.57 · 2023: $28.31 · 2024: $91.95 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $1,325.72 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $197.04 | 2022-2025 | Airsupra, Farxiga |
| Si-Bone, INC. | $95.46 | 2025 | |
| Welch Allyn | $52.60 | 2021 | |
| Intuitive Surgical, INC. | $50.17 | 2025 | |
| Lilly USA, LLC | $47.03 | 2023-2025 | Jardiance, Mounjaro |
| Novartis Pharmaceuticals Corporation | $41.91 | 2019 | |
| Pfizer INC. | $33.05 | 2025 | |
| Biom'Up Sa | $28.15 | 2019 | |
| Genentech USA, INC. | $25.78 | 2020-2021 | |
| Boston Scientific Corporation | $20.64 | 2025 | Wavewriter Alpha Prime 16 |
| Sumitomo Pharma America, INC. | $20.06 | 2024 | Gemtesa |
| Davol INC. | $18.85 | 2019 | |
| Abbvie INC. | $18.18 | 2025 | |
| Integra Lifesciences Corporation | $17.31 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tetraphase Pharmaceuticals, INC. | $15.63 | 2019 | |
| Medtronic, INC. | $15.19 | 2025 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.